- The Bateman Horne Center and Open Medicine Foundation recently released a highly anticipated ME and Long COVID clinical care guide. The 96-page guide has been praised by many in the community as a useful tool for clinicians, patients, and their families. “The goal of this guide is to equip providers with clear, actionable tools to better support their patients’ care journeys and help improve both daily function and long-term health outcomes,” the authors wrote.
- Researchers estimate a higher rate of new-onset diabetes after SARS-C0V-2 infection in a systematic review in Emerging Microbes and Infections. Based on data from 43 studies (totalling 4.4 million participants), the overall prevalence of new-onset diabetes after COVID-19 was 1.37%. “The risk of diabetes increases over time post-infection, with the highest prevalence observed between 3 to 12 months post-infection,” the authors wrote.
- A new preprint in Medxriv further demonstrates that Long COVID and ME are not deconditioning. Researchers compared the skeletal muscle abnormalities of healthy controls who rested in bed for 60 days to people with Long COVID and ME. The researchers found that people with Long COVID and ME who experience PEM had mitochondrial dysfunction, altered muscle fiber composition, and altered capillary supply, all distinct differences from the healthy controls who underwent bed rest. “These findings indicate that the lower exercise capacity in patients with Long COVID and ME/CFS is not solely due to physical inactivity,” the researchers concluded.
